BFM
NTUS

Boothbay Fund Management’s Natus Medical Inc NTUS Stock Holding History

Boothbay Fund Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,541
Closed -$217K – 897
2017
Q1 		$217K Buy
+5,541
New +$208K 0.04% 568

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

Boothbay Fund Management's NTUS Position: Q2 2017 in Review

Boothbay Fund Management sold out of Natus Medical Inc (NTUS) in Q2 2017, closing a stake of 5,541 shares — an estimated $217K sold.

Boothbay Fund Management first reported a position in NTUS in Q1 2017 and held it in 1 quarter. The position peaked at $217K in Q1 2017. 217 funds tracked by Wall St. Rank hold NTUS as of Q2 2017.

  • Boothbay Fund Management reported no remaining Natus Medical Inc position as of Q2 2017 after selling out during the quarter.
  • Boothbay Fund Management sold 5,541 Natus Medical Inc shares in Q2 2017, an estimated $217K.
  • Boothbay Fund Management first reported a position in Natus Medical Inc in Q1 2017 and held it in 1 quarter.
  • Boothbay Fund Management's Natus Medical Inc position peaked at $217K in Q1 2017.
  • 217 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2017.

Based on Boothbay Fund Management's 13F filing for Q2 2017, filed 14 Aug 2017.